tetano
Editor, Senior Moderator
Int Immunopharmacol
. 2023 Jun 8;121:110439.
doi: 10.1016/j.intimp.2023.110439. Online ahead of print. COVID-19 and severity of liver diseases: Possible crosstalk and clinical implications
Mohammad T Imam[SUP] 1 [/SUP], Ziyad S Almalki[SUP] 1 [/SUP], Abdullah R Alzahrani[SUP] 2 [/SUP], Saeed S Al-Ghamdi[SUP] 2 [/SUP], Alaa H Falemban[SUP] 2 [/SUP], Ibrahim M Alanazi[SUP] 2 [/SUP], Naiyer Shahzad[SUP] 2 [/SUP], Munira Muhammad Alrooqi[SUP] 3 [/SUP], Qaisar Jabeen[SUP] 4 [/SUP], Imran Shahid[SUP] 5 [/SUP]
Affiliations
COVID-19-infected individuals and those who recovered from the infection have been demonstrated to have elevated liver enzymes or abnormal liver biochemistries, particularly with preexisting liver diseases, liver metabolic disorders, viral hepatitis, and other hepatic comorbidities. However, possible crosstalk and intricate interplay between COVID-19 and liver disease severity are still elusive, and the available data are murky and confined. Similarly, the syndemic of other blood-borne infectious diseases, chemical-induced liver injuries, and chronic hepatic diseases continued to take lives while showing signs of worsening due to the COVID-19 crisis. Moreover, the pandemic is not over yet and is transitioning to becoming an epidemic in recent years; hence, monitoring liver function tests (LFTs) and assessing hepatic consequences of COVID-19 in patients with or without liver illnesses would be of paramount interest. This pragmatic review explores the correlations between COVID-19 and liver disease severity based on abnormal liver biochemistries and other possible mechanisms in individuals of all ages from the emergence of the COVID-19 pandemic to the post-pandemic period. The review also alludes to clinical perspectives of such interactions to curb overlapping hepatic diseases in people who recovered from the infection or living with long COVID-19.
Keywords: Acute liver disease; Chronic liver disease; Coronavirus infectious disease-19; Hepatic injury; Liver function test; Viral hepatitis.
. 2023 Jun 8;121:110439.
doi: 10.1016/j.intimp.2023.110439. Online ahead of print. COVID-19 and severity of liver diseases: Possible crosstalk and clinical implications
Mohammad T Imam[SUP] 1 [/SUP], Ziyad S Almalki[SUP] 1 [/SUP], Abdullah R Alzahrani[SUP] 2 [/SUP], Saeed S Al-Ghamdi[SUP] 2 [/SUP], Alaa H Falemban[SUP] 2 [/SUP], Ibrahim M Alanazi[SUP] 2 [/SUP], Naiyer Shahzad[SUP] 2 [/SUP], Munira Muhammad Alrooqi[SUP] 3 [/SUP], Qaisar Jabeen[SUP] 4 [/SUP], Imran Shahid[SUP] 5 [/SUP]
Affiliations
- PMID: 37315370
- DOI: 10.1016/j.intimp.2023.110439
COVID-19-infected individuals and those who recovered from the infection have been demonstrated to have elevated liver enzymes or abnormal liver biochemistries, particularly with preexisting liver diseases, liver metabolic disorders, viral hepatitis, and other hepatic comorbidities. However, possible crosstalk and intricate interplay between COVID-19 and liver disease severity are still elusive, and the available data are murky and confined. Similarly, the syndemic of other blood-borne infectious diseases, chemical-induced liver injuries, and chronic hepatic diseases continued to take lives while showing signs of worsening due to the COVID-19 crisis. Moreover, the pandemic is not over yet and is transitioning to becoming an epidemic in recent years; hence, monitoring liver function tests (LFTs) and assessing hepatic consequences of COVID-19 in patients with or without liver illnesses would be of paramount interest. This pragmatic review explores the correlations between COVID-19 and liver disease severity based on abnormal liver biochemistries and other possible mechanisms in individuals of all ages from the emergence of the COVID-19 pandemic to the post-pandemic period. The review also alludes to clinical perspectives of such interactions to curb overlapping hepatic diseases in people who recovered from the infection or living with long COVID-19.
Keywords: Acute liver disease; Chronic liver disease; Coronavirus infectious disease-19; Hepatic injury; Liver function test; Viral hepatitis.